ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Who Should We Ablate and Why?
Wednesday, June 15, 2016
Mark La Meir of Academic Hospital, Maastricht, the Netherlands, explains the rationale for the surgical treatment of atrial fibrillation. He describes the pathophysiology of atrial fibrillation, and examines the evidence for improved outcomes after surgical ablation.
This presentation was originally given during the SCTS Ionescu University program at the 2016 Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for more information on SCTS educational programs.
Printer-friendly
